Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 55 INDUSTRY 51 NIH 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 21 Sarcoma 14 Other hematologic neoplasm 12 CNS 10 Plasma cell 8 Genitourinary 5 Myeloid 3 Head & Neck 3 Dermatologic 3 Breast 3 Gynecologic 2 Thoracic 1 Other solid neoplasm 1 Other 1 Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 168 Lung Neoplasms 148 Adenocarcinoma of Lung 37 Small Cell Lung Carcinoma 23 Adenocarcinoma, Bronchiolo-Alveolar 20 Breast Neoplasms 15 Mesothelioma, Malignant 13 Colorectal Neoplasms 11 Colonic Neoplasms 10 Prostatic Neoplasms 9 Rectal Neoplasms 7 Ovarian Neoplasms 7 Breast Neoplasms, Male 7 Neoplasm Metastasis 6 Melanoma 6 Carcinoma, Ovarian Epithelial 6 Thymoma 5 Pleural Effusion, Malignant 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Pain 4 Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Salivary Gland Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Esthesioneuroblastoma, Olfactory 3 Esophageal Neoplasms 3

Interventions

Pharmaceutical Preparations 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Recurrence × Thoracic × Clear all

NCT07347977 2026-01-16

LidCRM

First Affiliated Hospital of Ningbo University

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡